Moreover, PLA2R1 promoter hypermethylation was found to be associated with aggressive subtypes of breast cancer, and PLA2R1 promoter hypermethylation was found to be a useful diagnostic and prognostic biomarker for breast cancer [17]. The gene discussed is PLA2R1; the disease is breast carcinoma.